CTI BIOPHARMA CORP: cash_and_restricted_cash

Value{"amount": 71881000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"}
Period (as of 2021-06-30)
Statuscurrent
EntityCTI BIOPHARMA CORP
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000891293-21-000041 · Open the official SEC filing →
Retrieved: 2026-08-19T08:57:46.154821+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000891293/cash-and-restricted-cash/2021-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/75ff24be-5120-41f1-92c0-7d4d719cbcf2

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies